{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:48:57Z","timestamp":1785944937240,"version":"3.56.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jinf.2014.08.005","type":"journal-article","created":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T02:25:14Z","timestamp":1412994314000},"page":"S63-S69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"S1","title":["Management of invasive group A streptococcal infections"],"prefix":"10.1016","volume":"69","author":[{"given":"Claire S.","family":"Waddington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Snelling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Carapetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1086\/431589","article-title":"Hospital-acquired invasive Group A streptococcal infections in Ontario, Canada, 1992\u20132000","volume":"41","author":"Daneman","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.005_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1440-1754.2007.01051.x","article-title":"Group A streptococcal infections in children","volume":"43","author":"Steer","year":"2007","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The working group on severe streptococcal infections","volume":"269","year":"1993","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.jinf.2014.08.005_bib4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-108-5-772_2","article-title":"Streptococcus pyogenes and the toxic shock syndrome","volume":"108","author":"Hribalova","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2014.08.005_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.micro.55.1.77","article-title":"Toxic shock syndrome and bacterial superantigens: an update","volume":"55","author":"McCormick","year":"2001","journal-title":"Annu Rev Microbiol"},{"issue":"5","key":"10.1016\/j.jinf.2014.08.005_bib6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/pch\/15.5.295","article-title":"Invasive Group A streptococcal disease: management and chemoprophylaxis","volume":"15","author":"Allen","year":"2010","journal-title":"Paediatr Child Health"},{"issue":"11","key":"10.1016\/j.jinf.2014.08.005_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of Group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2014.08.005_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJM199608223350803","article-title":"Invasive Group A streptococcal infections in Ontario, Canada. Ontario Group A streptococcal study group","volume":"335","author":"Davies","year":"1996","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ccc.2013.03.012","article-title":"Toxic shock syndrome: major advances in pathogenesis, but not treatment","volume":"29","author":"Low","year":"2013","journal-title":"Crit Care Clin"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive Group A streptococcal infections","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.005_bib12","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2013a comparative observational study. The Canadian Streptococcal Study Group","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2014.08.005_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/cid\/ciu449","article-title":"Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome \u2013 a comparative observational study","volume":"59","author":"Linner","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2014.08.005_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jinf.2011.11.001","article-title":"Guidelines for prevention and control of Group A streptococcal infection in acute healthcare and maternity settings in the UK","volume":"64","author":"Steer","year":"2012","journal-title":"J Infect"},{"issue":"Suppl 2","key":"10.1016\/j.jinf.2014.08.005_bib15","doi-asserted-by":"crossref","first-page":"B216","DOI":"10.1016\/j.vaccine.2012.09.045","article-title":"Group A streptococcal vaccines: paving a path for accelerated development","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2014.08.005_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/QCO.0b013e328332bbfe","article-title":"Group A streptococcal vaccines: facts versus fantasy","volume":"22","author":"Steer","year":"2009","journal-title":"Curr Opin Infect Dis"},{"issue":"30","key":"10.1016\/j.jinf.2014.08.005_bib17","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1016\/j.vaccine.2014.05.017","article-title":"Working towards a Group A streptococcal vaccine: report of a collaborative Trans-Tasman workshop","volume":"32","author":"Moreland","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.jinf.2014.08.005_bib18","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive Group A streptococcal infection and potential vaccine implications: United States, 2000\u20132004","volume":"45","author":"O'Loughlin","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2014.08.005_bib19","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe","volume":"46","author":"Lamagni","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2014.08.005_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5694\/j.1326-5377.2007.tb01054.x","article-title":"The epidemiology of invasive Group A streptococcal disease in Victoria,","volume":"186","author":"O'Grady","year":"2007","journal-title":"Aust Med J Aust"},{"issue":"9509","key":"10.1016\/j.jinf.2014.08.005_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(06)68180-4","article-title":"Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study","volume":"367","author":"Brent","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jinf.2014.08.005_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3201\/eid15\/2.080558","article-title":"Prospective surveillance of invasive Group A streptococcal disease, Fiji, 2005-2007","volume":"15","author":"Steer","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"Suppl","key":"10.1016\/j.jinf.2014.08.005_bib23","first-page":"148","article-title":"Invasive Group A streptococcal disease in North Queensland (1996\u20132001)","volume":"119","author":"Norton","year":"2004","journal-title":"Indian J Med Res"},{"issue":"1","key":"10.1016\/j.jinf.2014.08.005_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1017\/S0950268898001952","article-title":"Clinical and epidemiological features of Group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection","volume":"122","author":"Carapetis","year":"1999","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jinf.2014.08.005_bib25","unstructured":"Public Health England. Group A streptococcal infections [24\/06\/2014]. Available from: http:\/\/www.hpa.org.uk\/Topics\/InfectiousDiseases\/InfectionsAZ\/StreptococciGroupA."},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid0103.950301","article-title":"Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment","volume":"1","author":"Stevens","year":"1995","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198707163170305","article-title":"Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes","volume":"317","author":"Cone","year":"1987","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jinf.2014.08.005_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S095026880006739X","article-title":"Changes in the pattern of infection caused by Streptococcus pyogenes","volume":"100","author":"Gaworzewska","year":"1988","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.jinf.2014.08.005_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM198907063210101","article-title":"Severe Group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A","volume":"321","author":"Stevens","year":"1989","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib30","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1086\/341409","article-title":"Epidemiology of invasive Group A Streptococcus disease in the United States, 1995\u20131999","volume":"35","author":"O'Brien","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2014.08.005_bib31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/clinids\/21.5.1220","article-title":"Increasing severity of invasive Group A streptococcal disease in Australia: clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone","volume":"21","author":"Carapetis","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2014.08.005_bib32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1086\/606049","article-title":"Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest","volume":"49","author":"Valiquette","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2014.08.005_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1086\/428614","article-title":"Varicella-associated invasive Group A streptococcal disease in Alberta, Canada\u20132000\u20132002","volume":"40","author":"Tyrrell","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of Group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.jinf.2014.08.005_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.47.1.91","article-title":"The antigenic complex of Streptococcus haemolyticus : I. Demonstration of a type-specific substance in extracts of streptococcus haemolyticus","volume":"47","author":"Lancefield","year":"1928","journal-title":"J Exp Med"},{"issue":"5","key":"10.1016\/j.jinf.2014.08.005_bib36","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1111\/1469-0691.12134","article-title":"Updated model of Group A streptococcus M proteins based on a comprehensive worldwide study","volume":"19","author":"McMillan","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2014.08.005_bib37","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4049\/jimmunol.89.3.307","article-title":"Current knowledge of type-specific M antigens of Group A streptococci","volume":"89","author":"Lancefield","year":"1962","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2014.08.005_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/07853890252953464","article-title":"Molecular mechanisms of adhesion, colonization, and invasion of Group A streptococci","volume":"34","author":"Courtney","year":"2002","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.jinf.2014.08.005_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.tim.2010.02.007","article-title":"The streptococcal M protein: a highly versatile molecule","volume":"18","author":"Smeesters","year":"2010","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/CMR.2.3.285","article-title":"Streptococcal M protein: molecular design and biological behavior","volume":"2","author":"Fischetti","year":"1989","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.005_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(03)00576-0","article-title":"Molecular basis of Group A streptococcal virulence","volume":"3","author":"Bisno","year":"2003","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2014.08.005_bib42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(09)70178-1","article-title":"Global emm type distribution of Group A streptococci: systematic review and implications for vaccine development","volume":"9","author":"Steer","year":"2009","journal-title":"Lancet Infect Dis"},{"issue":"9290","key":"10.1016\/j.jinf.2014.08.005_bib43","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0140-6736(01)06415-7","article-title":"Dynamic epidemiology of Group A streptococcal serotypes associated with pharyngitis","volume":"358","author":"Kaplan","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.005_bib44","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1086\/315842","article-title":"Contrasting molecular epidemiology of Group A streptococci causing tropical and nontropical infections of the skin and throat","volume":"182","author":"Bessen","year":"2000","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.005_bib45","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/infdis\/173.4.896","article-title":"Genetic correlates of throat and skin isolates of Group A streptococci","volume":"173","author":"Bessen","year":"1996","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.005_bib46","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.vaccine.2009.10.137","article-title":"The emm-type diversity does not always reflect the M protein genetic diversity\u2013is there a case for designer vaccine against GAS","volume":"28","author":"Smeesters","year":"2010","journal-title":"Vaccine"},{"issue":"Pt 11","key":"10.1016\/j.jinf.2014.08.005_bib47","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1099\/jmm.0.2008\/002642-0","article-title":"Distribution of emm type and antibiotic susceptibility of Group A streptococci causing invasive and noninvasive disease","volume":"57","author":"Wajima","year":"2008","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.jinf.2014.08.005_bib48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/clinids\/14.1.298","article-title":"Severe streptococcal infections in historical perspective","volume":"14","author":"Katz","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jinf.2014.08.005_bib49","doi-asserted-by":"crossref","first-page":"475","DOI":"10.12968\/hmed.2009.70.8.43543","article-title":"The last year before the dawn of antibiotics","volume":"70","author":"Ellis","year":"2009","journal-title":"Br J Hosp Med"},{"issue":"12","key":"10.1016\/j.jinf.2014.08.005_bib50","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.jinf.2014.08.005_bib51","first-page":"1042","article-title":"Susceptibility and emm type of Streptococcus pyogenes isolated from children with severe infection. Journal of infection and chemotherapy","volume":"19","author":"Sakata","year":"2013","journal-title":"Off J Jpn Soc Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.005_bib52","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0924-8579(01)00413-7","article-title":"Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by Group A streptococci","volume":"18","author":"Mascini","year":"2001","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jinf.2014.08.005_bib53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jac\/40.2.275","article-title":"Comparative effects of clindamycin and ampicillin on superantigenic activity of Streptococcus pyogenes","volume":"40","author":"Sriskandan","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"11\u201312","key":"10.1016\/j.jinf.2014.08.005_bib54","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/00365540600836997","article-title":"Release of SpeA from Streptococcus pyogenes after exposure to penicillin: dependency on dose and inhibition by clindamycin","volume":"38","author":"Goscinski","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2014.08.005_bib55","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1172\/JCI116240","article-title":"Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]","volume":"91","author":"Takei","year":"1993","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2014.08.005_bib56","first-page":"3","article-title":"Mechanisms of action of intravenous immune globulin in immune-mediated diseases. Clinical and experimental immunology","volume":"104","author":"Mouthon","year":"1996"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.005_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10875-007-9088-9","article-title":"Intravenous immunoglobulin: an update on the clinical use and mechanisms of action","volume":"27","author":"Negi","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jinf.2014.08.005_bib58","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/978-1-4899-1825-3_130","article-title":"Superantigenic activity produced by Group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients","volume":"418","author":"Norrby-Teglund","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jinf.2014.08.005_bib59","first-page":"CD001090","article-title":"Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock","volume":"9","author":"Alejandria","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.jinf.2014.08.005_bib60","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/606048","article-title":"Intravenous immunoglobulin in children with streptococcal toxic shock syndrome","volume":"49","author":"Shah","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"25","key":"10.1016\/j.jinf.2014.08.005_bib61","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1056\/NEJM199606203342506","article-title":"Hyperbaric-oxygen therapy","volume":"334","author":"Tibbles","year":"1996","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jinf.2014.08.005_bib62","first-page":"847","article-title":"Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements","volume":"108","author":"Riseman","year":"1990","journal-title":"Surgery"},{"issue":"5","key":"10.1016\/j.jinf.2014.08.005_bib63","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0002-9610(94)90240-2","article-title":"A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy","volume":"167","author":"Brown","year":"1994","journal-title":"Am J Surg"},{"issue":"7","key":"10.1016\/j.jinf.2014.08.005_bib64","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/00006454-199507000-00007","article-title":"Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients","volume":"14","author":"Brogan","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.jinf.2014.08.005_bib65","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/096777209400200104","article-title":"Semmelweis: a rereading of Die aetiologie... Part I: puerperal sepsis before 1845; Die aetiologie","volume":"2","author":"Lancaster","year":"1994","journal-title":"J Med Biogr"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.005_bib66","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-147-4-200708210-00004","article-title":"Surveillance for hospital outbreaks of invasive Group A streptococcal infections in Ontario, Canada, 1992 to 2000","volume":"147","author":"Daneman","year":"2007","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jinf.2014.08.005_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/clinids\/17.1.79","article-title":"Intrapartum transmission of Group A streptococcus","volume":"17","author":"Panaro","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2014.08.005_bib68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/clinids\/15.2.277","article-title":"Clusters of invasive Group A streptococcal infections in family, hospital, and nursing home settings","volume":"15","author":"Schwartz","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"1 Pt 1","key":"10.1016\/j.jinf.2014.08.005_bib69","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1542\/peds.112.1.e61","article-title":"A family cluster of five cases of Group A streptococcal pneumonia","volume":"112","author":"Roy","year":"2003","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.jinf.2014.08.005_bib70","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/342692","article-title":"Prevention of invasive Group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the centers for disease control and prevention","volume":"35","author":"Prevention of Invasive Group ASIWP","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2014.08.005_bib71","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1086\/392496","article-title":"Meta-analysis of cephalosporins versus penicillin for treatment of Group A streptococcal tonsillopharyngitis in adults","volume":"38","author":"Casey","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445314002497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445314002497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:20:34Z","timestamp":1759008034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445314002497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":71,"alternative-id":["S0163445314002497"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2014.08.005","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of invasive group A streptococcal infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2014.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}